British Pound: Pound capped as bearish bias lingers against US Dollar – UOB
United Overseas Bank’s (UOB) Quek Ser Leang highlights that GBP/USD continues to lack clear momentum, with intraday action expected between 1.3175 and 1.3225. The bank maintains a negative 1–3 week view, seeing scope for a drop toward 1.3110 while strong resistance at 1.3245 caps upside. Over the 1–3 month horizon, the pair is still seen broadly range-bound.
Range trade persists with downside risk
"24-HOUR VIEW: Following last Thursday’s price action, we indicated on Friday that “there has been no shift in either downward or upward momentum, and the fluctuations appear to be part of a range-trading phase.” We expected GBP to “trade between 1.3160 and 1.3220.” GBP subsequently traded within a range of 1.3182/1.3232 before settling at 1.3211 (+0.16%). Momentum indicators are still mostly flat, and we continue to expect GBP to trade in a range, most likely between 1.3175 and 1.3225."
"1-3 WEEKS VIEW: We have held a negative GBP view since the middle of the month. In our most recent narrative from last Thursday (25 Jun, spot at 1.3165), we indicated that “there is a chance for GBP to drop to 1.3110.” Although GBP has since recovered, the weakness has not stabilised yet, and we will maintain our view as long as 1.3245 (no change in ‘strong resistance’ level) is not breached."
(This article was created with the help of an Artificial Intelligence tool and reviewed by an editor.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
As global tungsten prices surge, U.S. mining company Almonty Industries (ALM.US) quickly acquires a tungsten mine in Rwanda to ease supply shortages.
U.S. mining company Almonty Industries has signed a tungsten mining agreement in Rwanda, expanding Western supply.


Novo Nordisk (NVO.US) renamed to "Novo" for a fresh start—Can multi-line breakthroughs dispel the shadow over its stock price?
Danish pharmaceutical company Novo Nordisk (NVO.US) has launched a comprehensive rebranding centered around the shorter name "Novo." The company will use "Novo" in daily brand promotion, but its legal name will remain Novo Nordisk A/S.

High interest rates are not the "end" of US stocks? Is profitability the real key?
JPMorgan believes that profit growth is the key factor determining the resilience of U.S. stock valuations. Data since 1950 shows an "inverted U-shaped" relationship between the 10-year U.S. Treasury yield and S&P 500 valuations. Based on current profit levels, yields would need to reach about 5%-6% to significantly compress valuations. As long as profit growth remains above 15%, there is still room for valuations to be re-rated. If the yield curve steepens in a bear market, cyclical sectors such as energy and financials will benefit more; if it flattens, technology stocks will have a relative advantage.
